Supplier profile
UCB PHARMA, S.A.
Every public-sector award we hold for this supplier, across Spain, France and Portugal, from 30 Jun 2008 to 30 Sept 2026.
Awards won
325
all time
Attributed value
€112.6m
114 shared, unvalued
Buyers
144
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Gerencia de Servicio Sanitarios de Fuerteventura | 13 | €705k |
| Dirección General de Planificación Económica | 12 | €4.7m |
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 11 | €2.1m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 11 | €3.8m |
| Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 10 | €2.3m |
| Dirección Gerencia del Complejo Hospitalario Universitario de Canarias | 9 | €4.1m |
| Osakidetza | 9 | €5.9m |
| Consorci Sanitari Integral | 7 | €202k |
| Hospital General Universitario Gregorio Marañón | 6 | €2.1m |
| OSAKIDETZA - Servicio Vasco de Salud - Organización Central | 6 | €15.2m |
What they win
Awards
Showing 76–100 of 325 awards we hold
- l142 certolizumab pegol-cimzia ↗Inspección General de Sanidad de la Defensa€18kawarded 13 Sept 2024
- Spain – Pharmaceutical products – JAEN CBAM UCB PHARMA, S.A. AM 1108/2023 ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén€292kawarded 30 Aug 2024
- Spain – Various medicinal products – Suministro de productos farmacéuticos (Risankizumab, Lorlatinib, Dupilumab, Tucatinib y Bimekizumab), para el ComplejoHospitalario Universitario Insular-Materno Infantil de Gran Canaria. ↗Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantilshared awardawarded 24 Aug 2024
- Suministro de productos farmacéuticos (Risankizumab, Lorlatinib, Dupilumab, Tucatinib y Bimekizumab), para el ComplejoHospitalario Universitario Insular-Materno Infantil de Gran Canaria. ↗Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil€106kawarded 23 Aug 2024
- Spain – Antineoplastic and immunomodulating agents – PNSP HUPA 17/24 ↗HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS€123kawarded 3 Jul 2024
- Spain – Pharmaceutical products – Acuerdo Marco Suministro (CONTR 2023 0001044970) ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén.shared awardawarded 4 Jun 2024
- Suministro del medicamento Bimzelx 160 mg solución inyectable en pluma precargada 2 plumas precargadas (Principio activo Bimekizumab) de cuantía indeterminada (Disposición adicional 33 de la Ley 9/2017 de Contratos del Sector Público, mediante procedimiento negociado sin publicidad y tramitación ordinaria con destino al Servicio de Farmacia del HUNSC a realizar con la empresa Abbvie Spain SL ↗Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€165kawarded 23 May 2024
- Spain – Pharmaceutical products – Suministro del medicamento exclusivo Bimekizumab (BIMZELX) ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€306kawarded 8 May 2024
- Spain – Pharmaceutical products – Suministro de Fenfluramina(DOE) Y Bimekizumab (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€2.3mawarded 1 May 2024
- Spain – Pharmaceutical products – Suministro del medicamento BIMZELX 160 MG SOLUCION INYECTABLE en pluma precargada para el Área de Salud de Mérida. ↗Gerencia del Área de Salud de Mérida€113kawarded 11 Mar 2024
- Suministro del medicamento BIMZELX 160 MG SOLUCION INYECTABLE en pluma precargada para el Área de Salud de Mérida. ↗Gerencia del Área de Salud de Mérida€113kawarded 11 Mar 2024
- Spain – Pharmaceutical products – SUMINISTRO DE FÁRMACOS EXCLUSIVOS Y/O NO SUSTITUÍBLES ↗Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant Pau.shared awardawarded 6 Mar 2024
- El objeto del contrato viene determinado por el suministro del principio activo denominado "BIMEKIZUMAB 160 MG 1 MLSC". ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€47kawarded 26 Jan 2024
- Suministro de medicamentos exclusivos para los centros sanitarios dependientes del Servei de Salut de les Illes Balears ↗Servicio de Salud de las Illes Balearsshared awardawarded 26 Jan 2024
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€236kawarded 19 Jan 2024
- Spain-Barcelona: Various medicinal products ↗Consorci de Salut i d'Atenció Social de Catalunyashared awardawarded 29 Dec 2023
- Spain – Pharmaceutical products – Suministro de Efavirenz (DOE), Epoprostenol (DOE), Ambrisentan (DOE), Lacosamida (DOE), Voriconazol (DOE) y Ondansetron (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Centralshared awardawarded 13 Dec 2023
- Spain-Valls: Immunosuppressive agents ↗GESTIÓ PIUS HOSPITAL DE VALLS, SAMshared awardawarded 5 Dec 2023
- Spain-Valls: Immunosuppressive agents ↗GESTIÓ PIUS HOSPITAL DE VALLS, SAMshared awardawarded 5 Dec 2023
- Suministro de medicamentos uso humano II (medicamentos exclusivos ) con destino al Hospital Universitario Dr. José Molina Orosa de Lanzarote, mediante adhesión al acuerdo marco y tramitación anticipada ↗Gerencia de Servicios Sanitarios del Área de Salud de Lanzarote€157kawarded 28 Nov 2023
- Spain-Badalona: Immunosuppressive agents ↗Badalona Serveis Assistencials, SAshared awardawarded 27 Nov 2023
- Suministro farmacéutico del principio activo Bimekizumab 160 mg ↗Gerencia de Servicio Sanitarios de Fuerteventura€35kawarded 27 Oct 2023
- Spain-Terrassa: Immunosuppressive agents ↗Consorci Sanitari de Terrassashared awardawarded 13 Oct 2023
- Spain-Tortosa: Immunosuppressive agents ↗GESTIO SANITARIA I ASSISTENCIAL DE TORTOSA, S.A.M.shared awardawarded 10 Oct 2023
- Spain-Calella: Immunosuppressive agents ↗CORPORACIO DE SALUT DEL MARESME I LA SELVAshared awardawarded 10 Oct 2023
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.